FDA Adverse Event Other Summary report: N

SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE

MDR report key: 2222888 · Received August 10, 2011

Report

Report Number
1220423-2011-00032
Event Type
Other
Date Received
August 10, 2011
Report Date
August 4, 2011
Manufacturer
GENZYME BIOSURGERY (SEPRAFILM/PACK)
Product Code
MCN
PMA / PMN Number
P950034
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

MFR'S COMMENT: THE BENEFIT-RISK RELATIONSHIP OF SEPRAFILM IS NOT AFFECTED BY THIS REPORT. (B)(4).

Description of Event or Problem · 1

SUBCUTANEOUS ABSCESS (SLURRY) [SUBCUTANEOUS ABSCESS]. CASE DESCRIPTION: LITERATURE-TRIAL REPORT WAS RECEIVED ON (B)(4) 2011, FROM A PHYSICIAN REGARDING A PT (IDENTIFIERS NOT PROVIDED). THIS REPORT IS FROM A LITERATURE ARTICLE ENTITLED "SEPRAFILM SLURRY DOES NOT INCREASE COMPLICATION RATES AFTER LAPAROSCOPIC COLECTOMY". THERE WERE TWO GROUPS. GROUP 2 CONSISTED OF 50 PTS WHO UNDERWENT LAPAROSCOPIC COLECTOMY FOLLOWED BY THE APPLICATION OF THE SEPRAFILM SLURRY. THE SLURRY WAS CREATED AT THE END OF THE OPERATION BY DISSOLVING TWO PROCEDURE PACKS (EACH CONTAINING SIX 3X6 INCH SHEETS) OF SEPRAFILM IN 120 ML OF WARM NORMAL SALINE. THE SLURRY WAS DELIVERED INTO THE PERITONEAL CAVITY USING A 16-FR. ROBINSON CATHETER. ONE PT EXPERIENCED A SUBCUTANEOUS ABSCESS WHICH WAS MANAGED BY PERCUTANEOUS DRAINAGE AND ANTIBIOTICS. THE ACTION TAKEN WITH SEPRAFILM WAS NOT PROVIDED. THE PT'S OUTCOME WAS NOT PROVIDED. CONCOMITANT MEDICATIONS WERE NOT PROVIDED. THE RELATIONSHIP BETWEEN SEPRAFILM AND THE EVENT OF SUBCUTANEOUS ABSCESS WAS NOT PROVIDED BY THE REPORTING PHYSICIAN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE BIORESORBABLE ADHESION BARRIER MCN GENZYME BIOSURGERY (SEPRAFILM/PACK) UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention